Hemispherian has initiated a first-in-human Phase I/IIa trial of its oral small molecule, GLIX1, in patients with recurrent and progressive...
Global independent private equity fund Jeito Capital has closed its second fund, Jeito II, surpassing its target of €1bn ($1.2bn).The...
J&J has launched Varipulse Pro in Europe after securing CE Mark approval, strengthening its pulsed field ablation (PFA) portfolio.The post...
CatalYm has dosed the first patient in its Phase IIb GDFATHER-HCC-01 clinical trial, assessing visugromab along with chemoimmunotherapy as a...
Halozyme Hypercon has signed a global exclusive partnership and licence agreement with Vertex Pharmaceuticals for Hypercon technology.The post Halozyme and...
The post Rethinking the microbiology workflow with smarter tools for faster answers and less waste appeared first on Hospital Management. ...
As healthcare accelerates toward data intensive innovation, mounting pressure on hospital networks is exposing an uncomfortable truth: many are not...
Stereotaxis has launched the Synchrony system for cath laboratories after receiving 510(k) clearance from the FDA.The post Stereotaxis launches Synchrony...
Affinia Therapeutics has received approval from Health Canada for its CTA to begin the UPBEAT Phase I/II study of AFTX-201...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.